一种新的靶向APJ受体的基于apelin的PET放射性示踪剂的设计和临床前评估,用于血管生成的分子成像

IF 9.2 1区 医学 Q1 PERIPHERAL VASCULAR DISEASE
Béatrice Louis, Vincent Nail, Oriane Nachar, Ahlem Bouhlel, Anaïs Moyon, Laure Balasse, Stéphanie Simoncini, Adrien Chabert, Samantha Fernandez, Pauline Brige, Guillaume Hache, Aura Tintaru, Clément Morgat, Françoise Dignat-George, Philippe Garrigue, Benjamin Guillet
{"title":"一种新的靶向APJ受体的基于apelin的PET放射性示踪剂的设计和临床前评估,用于血管生成的分子成像","authors":"Béatrice Louis,&nbsp;Vincent Nail,&nbsp;Oriane Nachar,&nbsp;Ahlem Bouhlel,&nbsp;Anaïs Moyon,&nbsp;Laure Balasse,&nbsp;Stéphanie Simoncini,&nbsp;Adrien Chabert,&nbsp;Samantha Fernandez,&nbsp;Pauline Brige,&nbsp;Guillaume Hache,&nbsp;Aura Tintaru,&nbsp;Clément Morgat,&nbsp;Françoise Dignat-George,&nbsp;Philippe Garrigue,&nbsp;Benjamin Guillet","doi":"10.1007/s10456-023-09875-8","DOIUrl":null,"url":null,"abstract":"<div><p>APJ has been extensively described in the pathophysiology of angiogenesis and cell proliferation. The prognostic value of APJ overexpression in many diseases is now established. This study aimed to design a PET radiotracer that specifically binds to APJ. Apelin-F13A-NODAGA (AP747) was synthesized and radiolabeled with gallium-68 ([<sup>68</sup>Ga]Ga-AP747). Radiolabeling purity was excellent (&gt; 95%) and stable up to 2 h. Affinity constant of [<sup>67</sup>Ga]Ga-AP747 was measured on APJ-overexpressing colon adenocarcinoma cells and was in nanomolar range. Specificity of [<sup>68</sup>Ga]Ga-AP747 for APJ was evaluated in vitro by autoradiography and in vivo by small animal PET/CT in both colon adenocarcinoma mouse model and Matrigel plug mouse model. Dynamic of [<sup>68</sup>Ga]Ga-AP747 PET/CT biodistributions was realized on healthy mice and pigs for two hours, and quantification of signal in organs showed a suitable pharmacokinetic profile for PET imaging, largely excreted by urinary route. Matrigel mice and hindlimb ischemic mice were submitted to a 21-day longitudinal follow-up with [<sup>68</sup>Ga]Ga-AP747 and [<sup>68</sup>Ga]Ga-RGD<sub>2</sub> small animal PET/CT. [<sup>68</sup>Ga]Ga-AP747 PET signal in Matrigel was significantly more intense than that of [<sup>68</sup>Ga]Ga-RGD<sub>2</sub>. Revascularization of the ischemic hind limb was followed by LASER Doppler. In the hindlimb, [<sup>68</sup>Ga]Ga-AP747 PET signal was more than twice higher than that of [<sup>68</sup>Ga]Ga-RGD<sub>2</sub> on day 7, and significantly superior over the 21-day follow-up. A significant, positive correlation was found between the [<sup>68</sup>Ga]Ga-AP747 PET signal on day 7 and late hindlimb perfusion on day 21. We developed a new PET radiotracer that specifically binds to APJ, [<sup>68</sup>Ga]Ga-AP747 that showed more efficient imaging properties than the most clinically advanced tracer of angiogenesis, [<sup>68</sup>Ga]Ga-RGD<sub>2</sub>.\n</p></div>","PeriodicalId":7886,"journal":{"name":"Angiogenesis","volume":"26 3","pages":"463 - 475"},"PeriodicalIF":9.2000,"publicationDate":"2023-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s10456-023-09875-8.pdf","citationCount":"2","resultStr":"{\"title\":\"Design and preclinical evaluation of a novel apelin-based PET radiotracer targeting APJ receptor for molecular imaging of angiogenesis\",\"authors\":\"Béatrice Louis,&nbsp;Vincent Nail,&nbsp;Oriane Nachar,&nbsp;Ahlem Bouhlel,&nbsp;Anaïs Moyon,&nbsp;Laure Balasse,&nbsp;Stéphanie Simoncini,&nbsp;Adrien Chabert,&nbsp;Samantha Fernandez,&nbsp;Pauline Brige,&nbsp;Guillaume Hache,&nbsp;Aura Tintaru,&nbsp;Clément Morgat,&nbsp;Françoise Dignat-George,&nbsp;Philippe Garrigue,&nbsp;Benjamin Guillet\",\"doi\":\"10.1007/s10456-023-09875-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>APJ has been extensively described in the pathophysiology of angiogenesis and cell proliferation. The prognostic value of APJ overexpression in many diseases is now established. This study aimed to design a PET radiotracer that specifically binds to APJ. Apelin-F13A-NODAGA (AP747) was synthesized and radiolabeled with gallium-68 ([<sup>68</sup>Ga]Ga-AP747). Radiolabeling purity was excellent (&gt; 95%) and stable up to 2 h. Affinity constant of [<sup>67</sup>Ga]Ga-AP747 was measured on APJ-overexpressing colon adenocarcinoma cells and was in nanomolar range. Specificity of [<sup>68</sup>Ga]Ga-AP747 for APJ was evaluated in vitro by autoradiography and in vivo by small animal PET/CT in both colon adenocarcinoma mouse model and Matrigel plug mouse model. Dynamic of [<sup>68</sup>Ga]Ga-AP747 PET/CT biodistributions was realized on healthy mice and pigs for two hours, and quantification of signal in organs showed a suitable pharmacokinetic profile for PET imaging, largely excreted by urinary route. Matrigel mice and hindlimb ischemic mice were submitted to a 21-day longitudinal follow-up with [<sup>68</sup>Ga]Ga-AP747 and [<sup>68</sup>Ga]Ga-RGD<sub>2</sub> small animal PET/CT. [<sup>68</sup>Ga]Ga-AP747 PET signal in Matrigel was significantly more intense than that of [<sup>68</sup>Ga]Ga-RGD<sub>2</sub>. Revascularization of the ischemic hind limb was followed by LASER Doppler. In the hindlimb, [<sup>68</sup>Ga]Ga-AP747 PET signal was more than twice higher than that of [<sup>68</sup>Ga]Ga-RGD<sub>2</sub> on day 7, and significantly superior over the 21-day follow-up. A significant, positive correlation was found between the [<sup>68</sup>Ga]Ga-AP747 PET signal on day 7 and late hindlimb perfusion on day 21. We developed a new PET radiotracer that specifically binds to APJ, [<sup>68</sup>Ga]Ga-AP747 that showed more efficient imaging properties than the most clinically advanced tracer of angiogenesis, [<sup>68</sup>Ga]Ga-RGD<sub>2</sub>.\\n</p></div>\",\"PeriodicalId\":7886,\"journal\":{\"name\":\"Angiogenesis\",\"volume\":\"26 3\",\"pages\":\"463 - 475\"},\"PeriodicalIF\":9.2000,\"publicationDate\":\"2023-03-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://link.springer.com/content/pdf/10.1007/s10456-023-09875-8.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Angiogenesis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s10456-023-09875-8\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Angiogenesis","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s10456-023-09875-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 2

摘要

APJ在血管生成和细胞增殖的病理生理学中有广泛的描述。APJ过度表达在许多疾病中的预后价值现已确定。本研究旨在设计一种特异性结合APJ的PET放射性示踪剂。合成了Apelin-F13A-NODAGA(AP747),并用镓-68([68Ga]Ga-AP747)进行了放射性标记。放射标记纯度优异(>; 95%),并且稳定达2小时。在APJ过表达的结肠癌细胞上测量[67Ga]Ga-AP747的亲和常数,并且在纳摩尔范围内。在结肠腺癌小鼠模型和Matrigel栓小鼠模型中,通过放射自显影法在体外和通过小动物PET/CT在体内评估[68Ga]Ga-AP747对APJ的特异性。[68Ga]Ga-AP747 PET/CT生物分布的动态在健康小鼠和猪身上实现了两小时,器官中信号的定量显示出适合PET成像的药代动力学特征,主要通过尿液途径排泄。用[68Ga]Ga-AP747和[68Ga]Ga-RGD2小动物PET/CT对Matrigel小鼠和后肢缺血小鼠进行21天的纵向随访。Matrigel中的[68Ga]Ga-AP747PET信号明显比[68Ga]Ga-RGD2中的信号更强。用激光多普勒对缺血后肢进行血运重建。在后肢中,[68Ga]Ga-AP747 PET信号在第7天比[68Ga]Ga-RGD2高出两倍多,并且显著优于21天的随访。在第7天的[68Ga]Ga-AP747 PET信号和第21天的晚期后肢灌注之间发现了显著的正相关性。我们开发了一种与APJ特异性结合的新型PET放射性示踪剂[68Ga]Ga-AP747,其显示出比临床上最先进的血管生成示踪剂[68Ga]Ga-RGD2更有效的成像特性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Design and preclinical evaluation of a novel apelin-based PET radiotracer targeting APJ receptor for molecular imaging of angiogenesis

Design and preclinical evaluation of a novel apelin-based PET radiotracer targeting APJ receptor for molecular imaging of angiogenesis

Design and preclinical evaluation of a novel apelin-based PET radiotracer targeting APJ receptor for molecular imaging of angiogenesis

Design and preclinical evaluation of a novel apelin-based PET radiotracer targeting APJ receptor for molecular imaging of angiogenesis

APJ has been extensively described in the pathophysiology of angiogenesis and cell proliferation. The prognostic value of APJ overexpression in many diseases is now established. This study aimed to design a PET radiotracer that specifically binds to APJ. Apelin-F13A-NODAGA (AP747) was synthesized and radiolabeled with gallium-68 ([68Ga]Ga-AP747). Radiolabeling purity was excellent (> 95%) and stable up to 2 h. Affinity constant of [67Ga]Ga-AP747 was measured on APJ-overexpressing colon adenocarcinoma cells and was in nanomolar range. Specificity of [68Ga]Ga-AP747 for APJ was evaluated in vitro by autoradiography and in vivo by small animal PET/CT in both colon adenocarcinoma mouse model and Matrigel plug mouse model. Dynamic of [68Ga]Ga-AP747 PET/CT biodistributions was realized on healthy mice and pigs for two hours, and quantification of signal in organs showed a suitable pharmacokinetic profile for PET imaging, largely excreted by urinary route. Matrigel mice and hindlimb ischemic mice were submitted to a 21-day longitudinal follow-up with [68Ga]Ga-AP747 and [68Ga]Ga-RGD2 small animal PET/CT. [68Ga]Ga-AP747 PET signal in Matrigel was significantly more intense than that of [68Ga]Ga-RGD2. Revascularization of the ischemic hind limb was followed by LASER Doppler. In the hindlimb, [68Ga]Ga-AP747 PET signal was more than twice higher than that of [68Ga]Ga-RGD2 on day 7, and significantly superior over the 21-day follow-up. A significant, positive correlation was found between the [68Ga]Ga-AP747 PET signal on day 7 and late hindlimb perfusion on day 21. We developed a new PET radiotracer that specifically binds to APJ, [68Ga]Ga-AP747 that showed more efficient imaging properties than the most clinically advanced tracer of angiogenesis, [68Ga]Ga-RGD2.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Angiogenesis
Angiogenesis PERIPHERAL VASCULAR DISEASE-
CiteScore
21.90
自引率
8.20%
发文量
37
审稿时长
6-12 weeks
期刊介绍: Angiogenesis, a renowned international journal, seeks to publish high-quality original articles and reviews on the cellular and molecular mechanisms governing angiogenesis in both normal and pathological conditions. By serving as a primary platform for swift communication within the field of angiogenesis research, this multidisciplinary journal showcases pioneering experimental studies utilizing molecular techniques, in vitro methods, animal models, and clinical investigations into angiogenic diseases. Furthermore, Angiogenesis sheds light on cutting-edge therapeutic strategies for promoting or inhibiting angiogenesis, while also highlighting fresh markers and techniques for disease diagnosis and prognosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信